110 related articles for article (PubMed ID: 17364334)
1. High mobility group HMGI(Y) protein expression in head and neck squamous cell carcinoma.
Rho YS; Lim YC; Park IS; Kim JH; Ahn HY; Cho SJ; Shin HS
Acta Otolaryngol; 2007 Jan; 127(1):76-81. PubMed ID: 17364334
[TBL] [Abstract][Full Text] [Related]
2. Expression of HMGI(Y) associated with malignant phenotype of human gastric tissue.
Nam ES; Kim DH; Cho SJ; Chae SW; Kim HY; Kim SM; Han JJ; Shin HS; Park YE
Histopathology; 2003 May; 42(5):466-71. PubMed ID: 12713623
[TBL] [Abstract][Full Text] [Related]
3. HMGI(Y) gene expression in colorectal cancer: comparison with some histological typing, grading, and clinical staging.
Balcerczak M; Pasz-Walczak G; Balcerczak E; Wojtylak M; Kordek R; Mirowski M
Pathol Res Pract; 2003; 199(10):641-6. PubMed ID: 14666966
[TBL] [Abstract][Full Text] [Related]
4. Gene expressions of HMGI-C and HMGI(Y) are associated with stage and metastasis in colorectal cancer.
Huang ML; Chen CC; Chang LC
Int J Colorectal Dis; 2009 Nov; 24(11):1281-6. PubMed ID: 19609535
[TBL] [Abstract][Full Text] [Related]
5. Determination of high mobility group I(Y) expression level in colorectal neoplasias: a potential diagnostic marker.
Abe N; Watanabe T; Sugiyama M; Uchimura H; Chiappetta G; Fusco A; Atomi Y
Cancer Res; 1999 Mar; 59(6):1169-74. PubMed ID: 10096541
[TBL] [Abstract][Full Text] [Related]
6. Pancreatic duct cell carcinomas express high levels of high mobility group I(Y) proteins.
Abe N; Watanabe T; Masaki T; Mori T; Sugiyama M; Uchimura H; Fujioka Y; Chiappetta G; Fusco A; Atomi Y
Cancer Res; 2000 Jun; 60(12):3117-22. PubMed ID: 10866296
[TBL] [Abstract][Full Text] [Related]
7. Expression of the HMGI(Y) gene in human colorectal cancer.
Kim DH; Park YS; Park CJ; Son KC; Nam ES; Shin HS; Ryu JW; Kim DS; Park CK; Park YE
Int J Cancer; 1999 Aug; 84(4):376-80. PubMed ID: 10404089
[TBL] [Abstract][Full Text] [Related]
8. HMGI(Y) gene expression as a potential marker of thyroid follicular carcinoma.
Czyz W; Balcerczak E; Jakubiak M; Pasieka Z; Kuzdak K; Mirowski M
Langenbecks Arch Surg; 2004 Jun; 389(3):193-7. PubMed ID: 15107999
[TBL] [Abstract][Full Text] [Related]
9. The clinicopathological significances and biological functions of parafibromin expression in head and neck squamous cell carcinomas.
Zhang Z; Yang XF; Huang KQ; Ren L; Gou WF; Shen DF; Zhao S; Sun HZ; Takano Y; Zheng HC
Tumour Biol; 2015 Dec; 36(12):9487-97. PubMed ID: 26124004
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic significance of high mobility group I(Y) protein expression in intraductal papillary mucinous tumors of the pancreas.
Abe N; Watanabe T; Izumisato Y; Masaki T; Mori T; Sugiyama M; Chiappetta G; Fusco A; Fujioka Y; Atomi Y
Pancreas; 2002 Aug; 25(2):198-204. PubMed ID: 12142746
[TBL] [Abstract][Full Text] [Related]
11. Effect of 3q oncogenes SEC62 and SOX2 on lymphatic metastasis and clinical outcome of head and neck squamous cell carcinomas.
Bochen F; Adisurya H; Wemmert S; Lerner C; Greiner M; Zimmermann R; Hasenfus A; Wagner M; Smola S; Pfuhl T; Bozzato A; Al Kadah B; Schick B; Linxweiler M
Oncotarget; 2017 Jan; 8(3):4922-4934. PubMed ID: 28002801
[TBL] [Abstract][Full Text] [Related]
12. Expression and clinical significance of the Kv3.4 potassium channel subunit in the development and progression of head and neck squamous cell carcinomas.
Menéndez ST; Rodrigo JP; Allonca E; García-Carracedo D; Alvarez-Alija G; Casado-Zapico S; Fresno MF; Rodríguez C; Suárez C; García-Pedrero JM
J Pathol; 2010 Aug; 221(4):402-10. PubMed ID: 20593490
[TBL] [Abstract][Full Text] [Related]
13. High mobility group HMGI(Y) protein expression in human colorectal hyperplastic and neoplastic diseases.
Chiappetta G; Manfioletti G; Pentimalli F; Abe N; Di Bonito M; Vento MT; Giuliano A; Fedele M; Viglietto G; Santoro M; Watanabe T; Giancotti V; Fusco A
Int J Cancer; 2001 Jan; 91(2):147-51. PubMed ID: 11146437
[TBL] [Abstract][Full Text] [Related]
14. Detection of high mobility group I HMGI(Y) protein in the diagnosis of thyroid tumors: HMGI(Y) expression represents a potential diagnostic indicator of carcinoma.
Chiappetta G; Tallini G; De Biasio MC; Manfioletti G; Martinez-Tello FJ; Pentimalli F; de Nigris F; Mastro A; Botti G; Fedele M; Berger N; Santoro M; Giancotti V; Fusco A
Cancer Res; 1998 Sep; 58(18):4193-8. PubMed ID: 9751634
[TBL] [Abstract][Full Text] [Related]
15. Eps8 expression is significantly lower in p16
Nasri E; Wiesen LB; Knapik JA; Fredenburg KM
Hum Pathol; 2018 Feb; 72():45-51. PubMed ID: 29107665
[TBL] [Abstract][Full Text] [Related]
16. Expression of the high-mobility group protein HMGI(Y) in gestational trophoblastic diseases.
Briese J; Radde J; Schulte HM; Sajin M; Röser K; Löning T; Bamberger AM
Int J Gynecol Pathol; 2006 Jan; 25(1):65-9. PubMed ID: 16306787
[TBL] [Abstract][Full Text] [Related]
17. Expression of drug resistance-related genes in head and neck squamous cell carcinomas and normal mucosa.
Hirata S; Katoh O; Oguri T; Watanabe H; Yajin K
Jpn J Cancer Res; 2000 Jan; 91(1):84-90. PubMed ID: 10744048
[TBL] [Abstract][Full Text] [Related]
18. Expression of p53 and its homologues in primary and recurrent squamous cell carcinomas of the head and neck.
Weber A; Bellmann U; Bootz F; Wittekind C; Tannapfel A
Int J Cancer; 2002 May; 99(1):22-8. PubMed ID: 11948487
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of TACE and TIMP3 mRNA in head and neck cancer: association with tumour development and progression.
Kornfeld JW; Meder S; Wohlberg M; Friedrich RE; Rau T; Riethdorf L; Löning T; Pantel K; Riethdorf S
Br J Cancer; 2011 Jan; 104(1):138-45. PubMed ID: 21102583
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of cyclin D1 indicates a poor prognosis in squamous cell carcinoma of the head and neck.
Michalides RJ; van Veelen NM; Kristel PM; Hart AA; Loftus BM; Hilgers FJ; Balm AJ
Arch Otolaryngol Head Neck Surg; 1997 May; 123(5):497-502. PubMed ID: 9158396
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
